Effect of Omalizumab Therapy on Circulating Cytokine Profiles in Patients with Asthma–COPD Overlap Syndrome

Authors

  • Mobashshir Heyat MD, Assistant Professor, Department of Internal Medicine, JIMSH, Kolkata, India
  • Kabir Alam MD AIIMS, Patna, Bihar, India
  • Danish Ghazali MBBS, MEM (Int. Medicine), Consultant Physician Fortis Hospital
  • Faiqua Alam BDS, MIDA (New Delhi), M O Medwell Hospital

DOI:

https://doi.org/10.32553/ijmbs.v9i6.3178

Keywords:

ACOS

Abstract

This prospective observational research study included patients diagnosed with ACOS and treated with omalizumab as add-on therapy. Serum levels of key inflammatory cytokines were measured at baseline and after six months of treatment. Clinical and immunological changes were analyzed.

Downloads

Published

2025-12-30

How to Cite

Heyat, M. ., Alam, K. ., Ghazali, D. ., & Alam, F. . (2025). Effect of Omalizumab Therapy on Circulating Cytokine Profiles in Patients with Asthma–COPD Overlap Syndrome. International Journal of Medical and Biomedical Studies, 9(6), 150–153. https://doi.org/10.32553/ijmbs.v9i6.3178

Issue

Vol. 9 No. 6 (2025)

Section

Articles

License

Copyright (c) 2025 International Journal of Medical and Biomedical Studies

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.